Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Guardant Health, Inc.GH · Entity 3238 | Director · Co-Chief Executive Officer | September 30, 2026 | October 03, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Guardant Health, Inc.
Report date September 30, 2026 · Filed October 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectShares held by Helmy A. Eltoukhy Revocable Trust | 1,943,751 |
Reported balance
After 2026-09-30 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2026-09-30 · Exercise / conversion · Acquired 2,817 · Balance 1,943,751 |
| Common StockSEC Table I · non-derivative | IndirectShares held by Helmy A. Eltoukhy Revocable Trust | 1,942,323 |
Reported balance
After 2026-09-30 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2026-09-30 · Tax withholding · Disposed 1,428 · Balance 1,942,323 F1: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. |
| Common StockSEC Table I · non-derivative | IndirectShares held by Helmy A. Eltoukhy Revocable Trust | 1,966,320 |
Reported balance
After 2026-10-01 transaction · row 3
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 3 · 2026-10-01 · Exercise / conversion · Acquired 23,997 · Balance 1,966,320 |
| Common StockSEC Table I · non-derivative | IndirectShares held by Helmy A. Eltoukhy Revocable Trust | 1,976,036 |
Reported balance
After 2026-10-01 transaction · row 4
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 4 · 2026-10-01 · Exercise / conversion · Acquired 9,716 · Balance 1,976,036 |
| Common StockSEC Table I · non-derivative | IndirectShares held by Helmy A. Eltoukhy Revocable Trust | 1,958,949 |
Reported balance
After 2026-10-01 transaction · row 5
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 5 · 2026-10-01 · Tax withholding · Disposed 17,087 · Balance 1,958,949 F1: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 2,817 |
Reported balance
After 2026-09-30 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2026-09-30 · Exercise / conversion · Disposed 2,817 · Balance 2,817 F2: This represents a restricted stock unit award granted on March 17, 2026 that vests in four equal installments on the last day of each calendar quarter, March 31, 2026, June 30, 2026, September 30, 2026, and December 31, 2026. F3: Not applicable for Restricted Stock Units. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 23,998 |
Reported balance
After 2026-10-01 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2026-10-01 · Exercise / conversion · Disposed 23,997 · Balance 23,998 F4: This represents a restricted stock unit award granted on March 18, 2024 that vests over a three-year period. 33% of the shares subject to such award vested on January 1, 2025 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. F3: Not applicable for Restricted Stock Units. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 48,580 |
Reported balance
After 2026-10-01 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2026-10-01 · Exercise / conversion · Disposed 9,716 · Balance 48,580 F5: This represents a restricted stock unit award granted on March 12, 2025 that vests over a three-year period. 33% of the shares subject to such award vested on January 1, 2026 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. F3: Not applicable for Restricted Stock Units. |
Filing footnotes · ownership attribution and instrument terms
F1: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.
F2: This represents a restricted stock unit award granted on March 17, 2026 that vests in four equal installments on the last day of each calendar quarter, March 31, 2026, June 30, 2026, September 30, 2026, and December 31, 2026.
F3: Not applicable for Restricted Stock Units.
F4: This represents a restricted stock unit award granted on March 18, 2024 that vests over a three-year period. 33% of the shares subject to such award vested on January 1, 2025 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.
F5: This represents a restricted stock unit award granted on March 12, 2025 that vests over a three-year period. 33% of the shares subject to such award vested on January 1, 2026 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 31, 2025 Filed Jan 5, 2026 22:55 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCommon Stock | 2,441 | $102.14 | $249,323.74 |
DisclosureSEC source: 0001752968-26-000002 · wk-form4_1767653752.xml · nonDerivative · entry 2 Eltoukhy Helmy · CIK 0001752968 · Director · Co-Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,049,517 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| December 31, 2025 Filed Jan 5, 2026 22:55 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 4,815 | $0.00 | $0.00 |
DisclosureSEC source: 0001752968-26-000002 · wk-form4_1767653752.xml · nonDerivative · entry 1 Eltoukhy Helmy · CIK 0001752968 · Director · Co-Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,051,958 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 31, 2025 Filed Jan 22, 2026 22:43 UTC | Guardant Health, Inc. GH · Entity 3238 | OtherCommon Stock | 2,049,517 | $0.00 | $0.00 |
DisclosureSEC source: 0001752968-26-000004 · wk-form5_1769121779.xml · nonDerivative · entry 2 Eltoukhy Helmy · CIK 0001752968 · Director · Co-Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Indirect · Shares held by Helmy A. Eltoukhy Revocable Trust Disclosed balance after: 2,049,517 F1 · shares: Reflects changes in form of ownership from direct to indirect due to transfer of shares to Helmy A. Eltoukhy Revocable Trust. Read SEC document |
| December 31, 2025 Filed Jan 22, 2026 22:43 UTC | Guardant Health, Inc. GH · Entity 3238 | OtherCommon Stock | 2,049,517 | $0.00 | $0.00 |
DisclosureSEC source: 0001752968-26-000004 · wk-form5_1769121779.xml · nonDerivative · entry 1 Eltoukhy Helmy · CIK 0001752968 · Director · Co-Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,209 F1 · shares: Reflects changes in form of ownership from direct to indirect due to transfer of shares to Helmy A. Eltoukhy Revocable Trust. Read SEC document |
| December 15, 2025 Filed Dec 18, 2025 00:18 UTC | Guardant Health, Inc. GH · Entity 3238 | SaleCommon Stock | 6,620 | $104.02 | $688,628.29 |
DisclosureSEC source: 0001752968-25-000009 · wk-form4_1766017127.xml · nonDerivative · entry 2 Eltoukhy Helmy · CIK 0001752968 · Director · Co-Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,047,143 F2 · price: Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $104.020 to $104.055. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| December 15, 2025 Filed Dec 18, 2025 00:18 UTC | Guardant Health, Inc. GH · Entity 3238 | SaleCommon Stock | 83,945 | $103.80 | $8,713,591.73 |
DisclosureSEC source: 0001752968-25-000009 · wk-form4_1766017127.xml · nonDerivative · entry 1 Eltoukhy Helmy · CIK 0001752968 · Director · Co-Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,053,763 F1 · price: Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $103.02 to $104.01. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| October 01, 2025 Filed Oct 3, 2025 00:01 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 23,997 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001752968-25-000007 · wk-form4_1759449689.xml · derivative · entry 6 Eltoukhy Helmy · CIK 0001752968 · Director · Co-Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 119,986 Underlying: Common Stock · 23,997 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This represents a restricted stock unit award granted on March 18, 2024 that vests over a three year period. 33% of the shares subject to such award vested on January 1, 2025 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| October 01, 2025 Filed Oct 3, 2025 00:01 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCommon Stock | 12,162 | $62.65 | $761,949.30 |
DisclosureSEC source: 0001752968-25-000007 · wk-form4_1759449689.xml · nonDerivative · entry 4 Eltoukhy Helmy · CIK 0001752968 · Director · Co-Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,137,708 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| October 01, 2025 Filed Oct 3, 2025 00:01 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 23,997 | $0.00 | $0.00 |
DisclosureSEC source: 0001752968-25-000007 · wk-form4_1759449689.xml · nonDerivative · entry 3 Eltoukhy Helmy · CIK 0001752968 · Director · Co-Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,149,870 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 30, 2025 Filed Oct 3, 2025 00:01 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 4,814 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001752968-25-000007 · wk-form4_1759449689.xml · derivative · entry 5 Eltoukhy Helmy · CIK 0001752968 · Director · Co-Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,815 Underlying: Common Stock · 4,814 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This represents a restricted stock unit award granted on March 12, 2025 that vests in four equal installments on the last day of each calendar quarter, March 31, 2025, June 30, 2025, September 30, 2025, and December 31, 2025. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| September 30, 2025 Filed Oct 3, 2025 00:01 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCommon Stock | 2,440 | $62.48 | $152,451.20 |
DisclosureSEC source: 0001752968-25-000007 · wk-form4_1759449689.xml · nonDerivative · entry 2 Eltoukhy Helmy · CIK 0001752968 · Director · Co-Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,125,873 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| September 30, 2025 Filed Oct 3, 2025 00:01 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 4,814 | $0.00 | $0.00 |
DisclosureSEC source: 0001752968-25-000007 · wk-form4_1759449689.xml · nonDerivative · entry 1 Eltoukhy Helmy · CIK 0001752968 · Director · Co-Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,128,313 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 09, 2025 Filed Sep 11, 2025 23:14 UTC | Guardant Health, Inc. GH · Entity 3238 | SaleCommon Stock | 5,277 | $59.93 | $316,274.88 |
DisclosureSEC source: 0001752968-25-000005 · wk-form4_1757632483.xml · nonDerivative · entry 2 Eltoukhy Helmy · CIK 0001752968 · Director · Co-Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,123,499 F2 · shares: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.79 to $60.25 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 09, 2025 Filed Sep 11, 2025 23:14 UTC | Guardant Health, Inc. GH · Entity 3238 | SaleCommon Stock | 294,723 | $59.44 | $17,519,720.32 |
DisclosureSEC source: 0001752968-25-000005 · wk-form4_1757632483.xml · nonDerivative · entry 1 Eltoukhy Helmy · CIK 0001752968 · Director · Co-Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,128,776 F1 · shares: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.79 to $59.78 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 01, 2025 Filed Jul 3, 2025 01:16 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 23,997 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-25-000209 · wk-form4_1751505364.xml · derivative · entry 6 Eltoukhy Helmy · CIK 0001752968 · Director · Co-Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 143,983 Underlying: Common Stock · 23,997 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This restricted stock unit award vested with respect to 1/3 of the shares on January 1, 2025. The remaining shares vest quarterly for the remaining twenty-four months. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| July 01, 2025 Filed Jul 3, 2025 01:16 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCommon Stock | 12,162 | $50.71 | $616,735.02 |
DisclosureSEC source: 0001576280-25-000209 · wk-form4_1751505364.xml · nonDerivative · entry 4 Eltoukhy Helmy · CIK 0001752968 · Director · Co-Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,423,499 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| July 01, 2025 Filed Jul 3, 2025 01:16 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 23,997 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-25-000209 · wk-form4_1751505364.xml · nonDerivative · entry 3 Eltoukhy Helmy · CIK 0001752968 · Director · Co-Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,435,661 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 30, 2025 Filed Jul 3, 2025 01:16 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 4,815 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-25-000209 · wk-form4_1751505364.xml · derivative · entry 5 Eltoukhy Helmy · CIK 0001752968 · Director · Co-Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,629 Underlying: Common Stock · 4,815 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This represents a restricted stock unit award granted on March 12, 2025 that vests in four equal installments on the last day of each calendar quarter, March 31, 2025, June 30, 2025, September 30, 2025, and December 31, 2025. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| June 30, 2025 Filed Jul 3, 2025 01:16 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCommon Stock | 2,441 | $52.04 | $127,029.64 |
DisclosureSEC source: 0001576280-25-000209 · wk-form4_1751505364.xml · nonDerivative · entry 2 Eltoukhy Helmy · CIK 0001752968 · Director · Co-Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,411,664 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| June 30, 2025 Filed Jul 3, 2025 01:16 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 4,815 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-25-000209 · wk-form4_1751505364.xml · nonDerivative · entry 1 Eltoukhy Helmy · CIK 0001752968 · Director · Co-Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,414,105 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 01, 2025 Filed Apr 2, 2025 21:24 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 23,998 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-25-000104 · wk-form4_1743629083.xml · derivative · entry 6 Eltoukhy Helmy · CIK 0001752968 · Director · Co-Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 167,980 Underlying: Common Stock · 23,998 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This represents a restricted stock unit award granted on March 18, 2024 that vests over a three-year period. 33% of the shares subject to such award vested on January 1, 2025 and the remaining 67% of the shares vest in equal quarterly installments over the remaining two-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| April 01, 2025 Filed Apr 2, 2025 21:24 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCommon Stock | 12,163 | $42.47 | $516,562.61 |
DisclosureSEC source: 0001576280-25-000104 · wk-form4_1743629083.xml · nonDerivative · entry 4 Eltoukhy Helmy · CIK 0001752968 · Director · Co-Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,409,290 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| April 01, 2025 Filed Apr 2, 2025 21:24 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 23,998 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-25-000104 · wk-form4_1743629083.xml · nonDerivative · entry 3 Eltoukhy Helmy · CIK 0001752968 · Director · Co-Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,421,453 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 31, 2025 Filed Apr 2, 2025 21:24 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 4,814 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-25-000104 · wk-form4_1743629083.xml · derivative · entry 5 Eltoukhy Helmy · CIK 0001752968 · Director · Co-Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,444 Underlying: Common Stock · 4,814 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This represents a restricted stock unit award granted on March 12, 2025 that vests in four equal installments on the last day of each calendar quarter, March 31, 2025, June 30, 2025, September 30, 2025, and December 31, 2025. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| March 31, 2025 Filed Apr 2, 2025 21:24 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCommon Stock | 2,440 | $42.60 | $103,944.00 |
DisclosureSEC source: 0001576280-25-000104 · wk-form4_1743629083.xml · nonDerivative · entry 2 Eltoukhy Helmy · CIK 0001752968 · Director · Co-Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,397,455 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| March 31, 2025 Filed Apr 2, 2025 21:24 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 4,814 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-25-000104 · wk-form4_1743629083.xml · nonDerivative · entry 1 Eltoukhy Helmy · CIK 0001752968 · Director · Co-Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,399,895 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 14, 2025 Filed Mar 18, 2025 21:20 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionPerformance-Based Restricted Stock Units · Derivative | 68,769 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-25-000084 · wk-form4_1742332814.xml · derivative · entry 3 Eltoukhy Helmy · CIK 0001752968 · Director · Co-Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 68,769 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| March 14, 2025 Filed Mar 18, 2025 21:20 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCommon Stock | 34,853 | $42.89 | $1,494,845.17 |
DisclosureSEC source: 0001576280-25-000084 · wk-form4_1742332814.xml · nonDerivative · entry 2 Eltoukhy Helmy · CIK 0001752968 · Director · Co-Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,395,081 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| March 14, 2025 Filed Mar 18, 2025 21:20 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 68,769 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-25-000084 · wk-form4_1742332814.xml · nonDerivative · entry 1 Eltoukhy Helmy · CIK 0001752968 · Director · Co-Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,429,934 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 12, 2025 Filed Mar 13, 2025 20:34 UTC | Guardant Health, Inc. GH · Entity 3238 | GrantRestricted Stock Units · Derivative | 116,010 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-25-000072 · wk-form4_1741898050.xml · derivative · entry 2 Eltoukhy Helmy · CIK 0001752968 · Director · Co-Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 116,010 Underlying: Common Stock · 116,010 shares Expires not disclosed F3 · derivative.exercise_date: This represents a restricted stock unit award granted on March 12, 2025 that vests with respect to 33% of the shares on January 1, 2026 and the remaining 67% of the shares vest in equal quarterly installments over the remaining two-year period thereafter. F2 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| March 12, 2025 Filed Mar 13, 2025 20:34 UTC | Guardant Health, Inc. GH · Entity 3238 | GrantRestricted Stock Units · Derivative | 19,258 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-25-000072 · wk-form4_1741898050.xml · derivative · entry 1 Eltoukhy Helmy · CIK 0001752968 · Director · Co-Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,258 Underlying: Common Stock · 19,258 shares Expires not disclosed F1 · derivative.exercise_date: This represents a restricted stock unit award granted on March 12, 2025 that vests in four equal installments on the last day of each calendar quarter, March 31, 2025, June 30, 2025, September 30, 2025, and December 31, 2025. F2 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| January 01, 2025 Filed Jan 3, 2025 22:52 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 94,555 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-25-000004 · wk-form4_1735944758.xml · derivative · entry 6 Eltoukhy Helmy · CIK 0001752968 · Director · Co-Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 191,978 Underlying: Common Stock · 94,555 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This restricted stock unit award was granted on March 18, 2024 and vests with respect to 1/3 of the shares on January 1, 2025, and then quarterly for the remaining twenty-four months. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| January 01, 2025 Filed Jan 3, 2025 22:52 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCommon Stock | 43,309 | $30.55 | $1,323,089.95 |
DisclosureSEC source: 0001576280-25-000004 · wk-form4_1735944758.xml · nonDerivative · entry 4 Eltoukhy Helmy · CIK 0001752968 · Director · Co-Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,361,165 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| January 01, 2025 Filed Jan 3, 2025 22:52 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 94,555 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-25-000004 · wk-form4_1735944758.xml · nonDerivative · entry 3 Eltoukhy Helmy · CIK 0001752968 · Director · Co-Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,404,474 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 31, 2024 Filed Jan 3, 2025 22:52 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 11,462 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-25-000004 · wk-form4_1735944758.xml · derivative · entry 5 Eltoukhy Helmy · CIK 0001752968 · Director · Co-Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,462 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This restricted stock unit award was granted on March 18, 2024 and vests in four equal installments on the last day of each calendar quarter, March 31st, June 30th, September 30th, and December 31st, 2024. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| December 31, 2024 Filed Jan 3, 2025 22:52 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCommon Stock | 5,809 | $30.55 | $177,464.95 |
DisclosureSEC source: 0001576280-25-000004 · wk-form4_1735944758.xml · nonDerivative · entry 2 Eltoukhy Helmy · CIK 0001752968 · Director · Co-Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,309,919 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| December 31, 2024 Filed Jan 3, 2025 22:52 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 11,462 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-25-000004 · wk-form4_1735944758.xml · nonDerivative · entry 1 Eltoukhy Helmy · CIK 0001752968 · Director · Co-Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,315,728 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 30, 2024 Filed Oct 1, 2024 21:51 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 11,461 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000226 · wk-form4_1727819467.xml · derivative · entry 3 Eltoukhy Helmy · CIK 0001752968 · Director · Co-Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,462 Underlying: Common Stock · 11,461 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This restricted stock unit award will vest in four equal installments on the last day of each calendar quarter, 3/31, 6/30, 9/30, and 12/31. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| September 30, 2024 Filed Oct 1, 2024 21:51 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCommon Stock | 5,809 | $22.94 | $133,258.46 |
DisclosureSEC source: 0001576280-24-000226 · wk-form4_1727819467.xml · nonDerivative · entry 2 Eltoukhy Helmy · CIK 0001752968 · Director · Co-Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,304,266 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| September 30, 2024 Filed Oct 1, 2024 21:51 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 11,461 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000226 · wk-form4_1727819467.xml · nonDerivative · entry 1 Eltoukhy Helmy · CIK 0001752968 · Director · Co-Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,310,075 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 30, 2024 Filed Jul 2, 2024 20:47 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 11,462 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000158 · wk-form4_1719953239.xml · derivative · entry 3 Eltoukhy Helmy · CIK 0001752968 · Director · Co-Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,923 Underlying: Common Stock · 11,462 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This restricted stock unit award will vest in four equal installments on the last day of each calendar quarter, 3/31, 6/30, 9/30, and 12/31. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| June 30, 2024 Filed Jul 2, 2024 20:47 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCommon Stock | 5,809 | $28.88 | $167,763.92 |
DisclosureSEC source: 0001576280-24-000158 · wk-form4_1719953239.xml · nonDerivative · entry 2 Eltoukhy Helmy · CIK 0001752968 · Director · Co-Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,298,614 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| June 30, 2024 Filed Jul 2, 2024 20:47 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 11,462 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000158 · wk-form4_1719953239.xml · nonDerivative · entry 1 Eltoukhy Helmy · CIK 0001752968 · Director · Co-Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,304,423 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 03, 2024 Filed May 6, 2024 21:05 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionStock Option (Right to Buy) · Derivative | 200,000 | $0.00 Strike: $4.18 | $0.00 |
DisclosureSEC source: 0001576280-24-000100 · wk-form4_1715029495.xml · derivative · entry 2 Eltoukhy Helmy · CIK 0001752968 · Director · Co-Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 511,612 Underlying: Common Stock · 200,000 shares Expires 2027-07-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock option vests and becomes exercisable in equal monthly installments over 48 months commencing on April 23, 2017. Read SEC document |
| May 03, 2024 Filed May 6, 2024 21:05 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 200,000 | $4.18 | $836,000.00 |
DisclosureSEC source: 0001576280-24-000100 · wk-form4_1715029495.xml · nonDerivative · entry 1 Eltoukhy Helmy · CIK 0001752968 · Director · Co-Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,292,961 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 31, 2024 Filed Apr 1, 2024 21:20 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 11,461 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000072 · wk-form4_1712006381.xml · derivative · entry 3 Eltoukhy Helmy · CIK 0001752968 · Director · Co-Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,385 Underlying: Common Stock · 11,461 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This restricted stock unit award will vest in four equal installments on the last day of each calendar quarter, 3/31/2024, 6/30/2024, 9/30/2024, and 12/31/2024. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| March 31, 2024 Filed Apr 1, 2024 21:20 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCommon Stock | 4,509 | $20.63 | $93,020.67 |
DisclosureSEC source: 0001576280-24-000072 · wk-form4_1712006381.xml · nonDerivative · entry 2 Eltoukhy Helmy · CIK 0001752968 · Director · Co-Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,092,961 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| March 31, 2024 Filed Apr 1, 2024 21:20 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 11,461 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000072 · wk-form4_1712006381.xml · nonDerivative · entry 1 Eltoukhy Helmy · CIK 0001752968 · Director · Co-Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,097,470 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 18, 2024 Filed Mar 22, 2024 21:18 UTC | Guardant Health, Inc. GH · Entity 3238 | GrantRestricted Stock Units · Derivative | 286,533 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000068 · wk-form4_1711142280.xml · derivative · entry 3 Eltoukhy Helmy · CIK 0001752968 · Director · Co-Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 286,533 Underlying: Common Stock · 286,533 shares Expires not disclosed F6 · derivative.exercise_date: This restricted stock unit award will vest with respect to 1/3 of the shares on January 1, 2025, and then quarterly for the remaining 24 months. F5 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| March 18, 2024 Filed Mar 22, 2024 21:18 UTC | Guardant Health, Inc. GH · Entity 3238 | GrantRestricted Stock Units · Derivative | 45,846 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000068 · wk-form4_1711142280.xml · derivative · entry 2 Eltoukhy Helmy · CIK 0001752968 · Director · Co-Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,846 Underlying: Common Stock · 45,846 shares Expires not disclosed F4 · derivative.exercise_date: This restricted stock unit award will vest in four equal installments on the last day of each calendar quarter, 3/31/2024, 6/30/2024, 9/30/2024, and 12/31/2024. F5 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.